Pharma marketing tax breaks in danger?
Eliminating tax deductions for pharmaceutical marketing and advertising expenses may be discussed in Congress this year, although a stand-alone bill is unlikely to emerge, Coalition for Healthcare Communication Exec Director John Kamp said during a recent Drug Information Association session on DTC. "The idea of disfavoring marketing under the tax code has been around for some time," he noted, citing Sen. Ron Wyden, D-Wyo., and Rep. Pete Stark, D-Calif., as two legislators who have expressed interest in the concept...
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.